|
VRPX Virpax Pharmaceuticals Inc 1708331 |
| Income Statement |
|
Net Income
|
e6114_10q
|
-2,006,456 |
| Balance Sheet |
|
Current Assets
|
304,162 |
|
Assets
|
304,162 |
|
Current Liabilities
|
2,355,774 |
|
Liabilities
|
2,355,774 |
|
Equity
|
-2,051,612 |
|
Shares Out
|
4,888,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-13,842,213 |
| Market Analysis |
Market Cap
|
3,804,961 |
|
Price
|
0.30 |
|
BVPS
|
0.92 |
|
PB
|
0.33 |
|
EPS
|
-13.51 |
|
PS
|
0.04 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VRPX documents filed with the SEC.
VRPX Filings
Clear
